182 related articles for article (PubMed ID: 30914724)
1. The ATP-gated P2X
El Mdawar MB; Maître B; Magnenat S; Gachet C; Hechler B; de la Salle H
Sci Rep; 2019 Mar; 9(1):5159. PubMed ID: 30914724
[TBL] [Abstract][Full Text] [Related]
2. ATP-gated P2X1 ion channels protect against endotoxemia by dampening neutrophil activation.
Lecut C; Faccinetto C; Delierneux C; van Oerle R; Spronk HM; Evans RJ; El Benna J; Bours V; Oury C
J Thromb Haemost; 2012 Mar; 10(3):453-65. PubMed ID: 22212928
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
El-Ajouz S; Ray D; Allsopp RC; Evans RJ
Br J Pharmacol; 2012 Jan; 165(2):390-400. PubMed ID: 21671897
[TBL] [Abstract][Full Text] [Related]
4. A fluorescent approach for identifying P2X1 ligands.
Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ
Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism.
Johansson KE; Ståhl AL; Arvidsson I; Loos S; Tontanahal A; Rebetz J; Chromek M; Kristoffersson AC; Johannes L; Karpman D
Sci Rep; 2019 Oct; 9(1):14362. PubMed ID: 31591425
[TBL] [Abstract][Full Text] [Related]
6. Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer LK; Schmid R; Evans RJ
J Biol Chem; 2015 Jan; 290(3):1559-69. PubMed ID: 25425641
[TBL] [Abstract][Full Text] [Related]
7. P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.
Allsopp RC; Farmer LK; Fryatt AG; Evans RJ
J Biol Chem; 2013 Jul; 288(29):21412-21421. PubMed ID: 23740251
[TBL] [Abstract][Full Text] [Related]
8. Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis.
Wang X; Yuan X; Su Y; Hu J; Ji Q; Fu S; Li R; Hu L; Dai C
Front Immunol; 2021; 12():696766. PubMed ID: 34354708
[TBL] [Abstract][Full Text] [Related]
9. Targeting P2RX1 alleviates renal ischemia/reperfusion injury by preserving mitochondrial dynamics.
Zhuang S; Xia S; Huang P; Wu J; Qu J; Chen R; Sun N; Li D; Wu H; Zhang M; Zhang J; Yuan X; Wang X
Pharmacol Res; 2021 Aug; 170():105712. PubMed ID: 34091010
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
11. NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
Braun K; Rettinger J; Ganso M; Kassack M; Hildebrandt C; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):285-90. PubMed ID: 11521173
[TBL] [Abstract][Full Text] [Related]
12. Impaired P2X1 Receptor-Mediated Adhesion in Eosinophils from Asthmatic Patients.
Wright A; Mahaut-Smith M; Symon F; Sylvius N; Ran S; Bafadhel M; Muessel M; Bradding P; Wardlaw A; Vial C
J Immunol; 2016 Jun; 196(12):4877-84. PubMed ID: 27183585
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury.
Yu Y; Jiang P; Sun P; Su N; Lin F
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165170
[TBL] [Abstract][Full Text] [Related]
14. Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse.
Hechler B; Maître B; Magnenat S; Heim V; El Mdawar MB; Gachet C; de la Salle H
J Thromb Haemost; 2016 Jun; 14(6):1255-67. PubMed ID: 27063192
[TBL] [Abstract][Full Text] [Related]
15. P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.
Darbousset R; Delierneux C; Mezouar S; Hego A; Lecut C; Guillaumat I; Riederer MA; Evans RJ; Dignat-George F; Panicot-Dubois L; Oury C; Dubois C
Blood; 2014 Oct; 124(16):2575-85. PubMed ID: 25150292
[TBL] [Abstract][Full Text] [Related]
16. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
Hausmann R; Schmalzing G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
[TBL] [Abstract][Full Text] [Related]
17. Preventing murine transfusion-related acute lung injury by expansion of CD4
He R; Li L; Kong Y; Tian L; Tian X; Fang P; Bian M; Liu Z
Transfusion; 2019 Feb; 59(2):534-544. PubMed ID: 30499590
[TBL] [Abstract][Full Text] [Related]
18. P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1.
Hinze AV; Mayer P; Harst A; von Kügelgen I
Purinergic Signal; 2013 Dec; 9(4):677-86. PubMed ID: 23873636
[TBL] [Abstract][Full Text] [Related]
19. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.
Huang Z; Liu P; Zhu L; Li N; Hu H
Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation.
Kapur R; Kasetty G; Rebetz J; Egesten A; Semple JW
Blood; 2019 Jul; 134(1):74-84. PubMed ID: 31076444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
